Viewing Study NCT03458650


Ignite Creation Date: 2025-12-24 @ 5:12 PM
Ignite Modification Date: 2025-12-27 @ 6:09 AM
Study NCT ID: NCT03458650
Status: COMPLETED
Last Update Posted: 2018-05-30
First Post: 2018-01-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Study of LuoXin Innovate (LXI-15028) in Healthy Chinese Subjects to Evaluate the Pharmacokinetics, Safety and Tolerability.
Sponsor: Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module